139 related articles for article (PubMed ID: 5766980)
1. Coronary vasodilator responses to hypoxia and induced tachycardia before and after lidoflazine.
Afonso S
Am J Physiol; 1969 Feb; 216(2):297-300. PubMed ID: 5766980
[No Abstract] [Full Text] [Related]
2. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
Takenaka T; Tachikawa S
Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
[No Abstract] [Full Text] [Related]
3. Potentiation of adenosine activity by low oral doses of lidoflazine.
Jageneau AH; Schaper WK
Nature; 1969 Jan; 221(5176):184-5. PubMed ID: 5782714
[No Abstract] [Full Text] [Related]
4. Enhancement of coronary vasodilating action of ATP and adenosine by lidoflazine.
Afonso S; O'Brien GS; Crumpton CW
Circ Res; 1968 Jan; 22(1):43-8. PubMed ID: 5635208
[No Abstract] [Full Text] [Related]
5. Effects of lidoflazine in atrial muscle.
Ilhan M; Kayaalp SO
Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
[No Abstract] [Full Text] [Related]
6. The systemic and coronary hemodynamic effects of lidoflazine.
Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
[No Abstract] [Full Text] [Related]
7. Pharmacological effects on coronary reactive hyperemia in conscious dogs.
Juhran W; Voss EM; Dietmann K; Schaumann W
Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):32-47. PubMed ID: 4252441
[No Abstract] [Full Text] [Related]
8. Enhancement of coronary reactive hyperemia in unanesthetized pigs by an adenosine-potentiator (Lidoflazine).
Jageneau AH; Schaper WK; Van Gerven W
Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):16-23. PubMed ID: 4254217
[No Abstract] [Full Text] [Related]
9. [Screening of substances with coronary vasodilator action].
Lenke D
Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
[No Abstract] [Full Text] [Related]
10. [Experimental research on the coronary dilatory action of benzydryl-1-piperonylpiperazine in the intact dog].
Laubie M; Schmitt H
Arch Int Pharmacodyn Ther; 1965 May; 155(1):1-6. PubMed ID: 5834935
[No Abstract] [Full Text] [Related]
11. The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator.
Schaper WK; Xhoneux R; Jageneau AH; Janssen PA
J Pharmacol Exp Ther; 1966 May; 152(2):265-74. PubMed ID: 5944369
[No Abstract] [Full Text] [Related]
12. [Effect of oxyfedrine on the blood flow of coronary vessels in intra- and extramural regions (studies on the dog)].
Düx A; Hahn N; Felix R; Draznin N; Meuser HJ
Arzneimittelforschung; 1969 Mar; 19(3):300-4. PubMed ID: 5818776
[No Abstract] [Full Text] [Related]
13. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
Afonso S; O'Brien GS; Berndt TB; Ansfield TJ; Rowe GG
J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
[No Abstract] [Full Text] [Related]
14. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
Lochner W
Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
[No Abstract] [Full Text] [Related]
15. Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
Sano N; Sato S; Hashimoto K
Jpn J Pharmacol; 1972 Dec; 22(6):857-65. PubMed ID: 4541491
[No Abstract] [Full Text] [Related]
16. [Comparative studies on the effect of coronary dilators on the coronary blood circulation in man].
Hilger HH; Behrenbeck DW; Hellwig H; Wagner J
Arzneimittelforschung; 1970 Mar; 20():441-2. PubMed ID: 5468726
[No Abstract] [Full Text] [Related]
17. The cardiovascular pharmacology of lidoflazine.
Schaper W; Jageneau A; Xhonneux R
Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
[No Abstract] [Full Text] [Related]
18. Coronary collateral vasodilator action of N-ethoxycarbonyl-3-morpholinosydnonimine (SIN-10) in heart with chronic coronary insufficiency in dogs.
Hirata M; Kikuchi K
Jpn J Pharmacol; 1970 Jun; 20(2):187-93. PubMed ID: 5311558
[No Abstract] [Full Text] [Related]
19. Stimulation of the coronary collateral circulation by lidoflazine (R 7904).
Schaper WK; Xhonneux R; Jageneau AH
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):1-8. PubMed ID: 4222721
[No Abstract] [Full Text] [Related]
20. Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).
Sato M; Nagao T; Yamaguchi I; Nakajima H; Kiyomoto A
Arzneimittelforschung; 1971 Sep; 21(9):1338-43. PubMed ID: 5171789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
